APOB and metabolic syndrome: Insulin resistant cardiometabolic disease often entails an ‘atherogenic dyslipidemia’, characterized by elevated plasma TG, low HDL-C levels, a preponderance of small, dense LDL particles, and elevated apolipoproteins (apo) B (apoB 100 and apoB48) and C-III concentrations [25, 26].